FDA OKs Steroid Insert (Dextenza) for Postop Ocular Pain

Dextenza is the first FDA-approved intracanalicular insert that delivers dexamethasone to treat ocular pain following ophthalmic surgery for up to 30 days with a single insertion.
FDA Approvals

Full Story →